Mostrar o rexistro simple do ítem

dc.contributor.authorVázquez Agra, Nestor*
dc.contributor.authorMarques Afonso, Ana Teresa*
dc.contributor.authorCruces-Sande, A.*
dc.contributor.authorMendez-Alvarez, E.*
dc.contributor.authorSoto-Otero, R.*
dc.contributor.authorLopez Paz, Jose Enrique *
dc.contributor.authorPose Reino, Antonio *
dc.contributor.authorHermida Ameijeiras, Alvaro *
dc.date.accessioned2025-09-08T09:15:38Z
dc.date.available2025-09-08T09:15:38Z
dc.date.issued2023
dc.identifier.citationVazquez-Agra N, Marques-Afonso A-T, Cruces-Sande A, Mendez-Alvarez E, Soto-Otero R, Lopez-Paz J-E, et al. Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers. Antioxidants. 2023;12(4).
dc.identifier.issn2076-3921
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/64609f19c6d6be6c90fc60b2
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21109
dc.description.abstractAs in other fields, chronotherapy applied to arterial hypertension (AHT) may have implications on oxidative stress. We compared the levels of some redox markers between hypertensive patients with morning and bedtime use of renin-angiotensin-aldosterone system (RAAS) blockers. This was an observational study that included patients older than 18 years with a diagnosis of essential AHT. Blood pressure (BP) figures were measured using twenty-four-hour ambulatory BP monitoring (24-h ABPM). Lipid peroxidation and protein oxidation were assessed using the thiobarbituric acid reactive substances (TBARS) and reduced thiols assays. We recruited 70 patients with a median age of 54 years, of whom 38 (54%) were women. In hypertensive patients with bedtime use of RAAS blockers, reduced thiol levels showed a positive correlation with nocturnal diastolic BP decrease. TBARS levels were associated with bedtime use of RAAS blockers in dipper and non-dipper hypertensive patients. In non-dipper patients, bedtime use of RAAS blockers was also associated with a decrease in nocturnal diastolic BP. Chronotherapy applied to bedtime use of some BP-lowering drugs in hypertensive patients may be linked to a better redox profile.
dc.languageeng
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleAssessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers
dc.typeArtigo
dc.authorsophosVazquez-Agra, N.; Marques-Afonso, A.-T.; Cruces-Sande, A.; Mendez-Alvarez, E.; Soto-Otero, R.; Lopez-Paz, J.-E.; Pose-Reino, A.; Hermida-Ameijeiras, A.
dc.identifier.doi10.3390/antiox12040802
dc.identifier.sophos64609f19c6d6be6c90fc60b2
dc.issue.number4
dc.journal.titleAntioxidants*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Docencia
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Medicina interna
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Medicina interna
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Medicina interna
dc.relation.publisherversionhttps://doi.org/10.3390/antiox12040802
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.subject.keywordAS Santiago
dc.subject.keywordIDIS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number12


Ficheiros no ítem

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem

Attribution 4.0 International (CC BY 4.0)
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAttribution 4.0 International (CC BY 4.0)